Aorto-carotid bypass in patients with Takayasu arteritis

Hong Han, Kyoung Won Yoon, Seon-Hee Heo, Yang‐Jin Park, Young-Wook Kim, Dong‐Ik KimAnnals 2017 · DOI

Abstract

Aorto-carotid bypass is an effective surgical intervention for patients with Takayasu arteritis (TA) experiencing severe cerebrovascular ischemia. This retrospective study of 19 patients evaluates the safety and long-term efficacy of the procedure. While the bypass successfully resolves ischemic symptoms, it carries a significant risk of intracranial hemorrhage (ICH). The findings indicate that strict postoperative blood pressure (BP) management, specifically maintaining systolic BP below 180 mmHg, is critical to preventing catastrophic hemorrhagic complications.

Introduction

Takayasu arteritis, often referred to as "pulseless disease," is a chronic inflammatory condition that primarily targets the aorta and its major branches. In advanced stages, the resulting fibrosis leads to severe arterial stenosis or total occlusion, particularly in the carotid arteries. For patients who do not respond to medical therapy or who present with debilitating neurological symptoms such as syncope and vision loss, surgical bypass is often necessary to restore cerebral perfusion.

3D CT reconstruction of the neck and upper thoracic vessels, illustrating the complex vascular involvement in Takayasu arteritis.

Pathological and Clinical Profile

The study analyzed 19 female patients (mean age 40.6 years) who underwent aorto-carotid bypass. Histopathological examination of the affected vessels typically reveals granulomatous inflammation, a hallmark of the disease's active phase. This underlying pathology necessitates careful pre-operative stabilization with steroids or immunosuppressants to normalize inflammatory markers before surgical intervention.

Histopathological sections (H&E stain) of an arterial wall in Takayasu arteritis. (A) shows extensive wall thickening and fibrosis; (B) highlights granulomatous inflammation with multinucleated giant cells.

Surgical Methodology and Outcomes

The procedures included both aorto-uni-carotid (n=11) and aorto-bi-carotid (n=8) bypasses using synthetic or vein grafts. The primary outcome was the successful resolution of cerebrovascular symptoms in all surviving patients. However, the study highlighted a significant complication rate:

  • Intracranial Hemorrhage (ICH): Occurred in 26.3% (5/19) of patients, all within the first eight days post-surgery.
  • The BP Link: A strong statistical correlation (P = 0.045) was found between postoperative systolic BP exceeding 180 mmHg and the occurrence of ICH. Notably, no patients in the "controlled BP" group suffered a hemorrhage.
  • Mortality: The mortality rate was 15.8%, primarily due to ICH or subsequent infarction.
  • Hyperperfusion Syndrome: Approximately 21% of patients experienced transient symptoms like seizures or headaches, attributed to the sudden restoration of high-pressure blood flow to previously under-perfused brain tissue.

Conclusion

Aorto-carotid bypass provides definitive relief for the ischemic symptoms of Takayasu arteritis. However, the risk of hyperperfusion-related intracranial hemorrhage is substantial. To ensure surgical success, clinicians must prioritize strict postoperative blood pressure regulation. Future research with larger cohorts is needed to further refine these management protocols and assess long-term graft patency in this progressive disease.

Summary updated

Abstract

Aorto-carotid bypass is effective for treating Takayasu arteritis with cerebrovascular ischemia, and the results suggest that postoperative blood pressure should be strictly managed to prevent intracranial hemorrhage.
BibTeX
@article{han2017aorto,
  author = {Hong Han and Kyoung Won Yoon and Seon-Hee Heo and Yang‐Jin Park and Young-Wook Kim and Dong‐Ik Kim},
  title = {{Aorto-carotid bypass in patients with Takayasu arteritis}},
  journal = {Annals},
  year = {2017},
  doi = {10.4174/astr.2017.93.3.143},
}
Figure